Follow
Martín A. Rivas
Martín A. Rivas
University of Miami Miller School of Medicine
Verified email at med.miami.edu - Homepage
Title
Cited by
Cited by
Year
Early adaptation and acquired resistance to CDK4/6 inhibition in estrogen receptor–positive breast cancer
MT Herrera-Abreu, M Palafox, U Asghar, MA Rivas, RJ Cutts, ...
Cancer research 76 (8), 2301-2313, 2016
6322016
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways
MA Rivas, RP Carnevale, CJ Proietti, C Rosemblit, W Beguelin, ...
Experimental cell research 314 (3), 509-529, 2008
2042008
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop
W Béguelin, MA Rivas, MT Calvo Fernández, M Teater, A Purwada, ...
Nature communications 8 (1), 877, 2017
1622017
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis
AD Viny, CJ Ott, B Spitzer, M Rivas, C Meydan, E Papalexi, D Yelin, ...
Journal of Experimental Medicine 212 (11), 1819-1832, 2015
1522015
TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis
PM Dominguez, H Ghamlouch, W Rosikiewicz, P Kumar, W Béguelin, ...
Cancer discovery 8 (12), 1632-1653, 2018
1462018
Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response
W Béguelin, M Teater, C Meydan, KB Hoehn, JM Phillip, AA Soshnev, ...
Cancer cell 37 (5), 655-673. e11, 2020
1162020
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3
W Béguelin, MC Díaz Flaqué, CJ Proietti, F Cayrol, MA Rivas, M Tkach, ...
Molecular and cellular biology 30 (23), 5456-5472, 2010
1162010
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
MA Rivas, L Venturutti, YW Huang, R Schillaci, THM Huang, PV Elizalde
Breast cancer research 14, 1-21, 2012
1152012
TNFα-induced mucin 4 expression elicits trastuzumab resistance in HER2-positive breast cancer
MF Mercogliano, M De Martino, L Venturutti, MA Rivas, CJ Proietti, ...
Clinical Cancer Research 23 (3), 636-648, 2017
1042017
p42/p44 MAPK-mediated Stat3 Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth
M Tkach, C Rosemblit, MA Rivas, CJ Proietti Anastasi, MC Díaz Flaqué, ...
Bioscientifica, 2013
992013
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
L Venturutti, RI Cordo Russo, MA Rivas, MF Mercogliano, F Izzo, ...
Oncogene 35 (48), 6189-6202, 2016
822016
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
CJ Proietti, C Rosemblit, W Beguelin, MA Rivas, MC Díaz Flaqué, ...
Molecular and cellular biology 29 (5), 1249-1265, 2009
712009
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization
AP Gomes, D Ilter, V Low, A Rosenzweig, ZJ Shen, T Schild, MA Rivas, ...
Cancer Cell 36 (4), 402-417. e13, 2019
702019
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells
M Tkach, L Coria, C Rosemblit, MA Rivas, CJ Proietti, MC Díaz Flaqué, ...
The Journal of Immunology 189 (3), 1162-1172, 2012
552012
BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells
E Valls, C Lobry, H Geng, L Wang, M Cardenas, M Rivas, L Cerchietti, ...
Cancer discovery 7 (5), 506-521, 2017
502017
Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model
T Durfort, M Tkach, MI Meschaninova, MA Rivas, PV Elizalde, ...
PLoS One 7 (1), e29213, 2012
502012
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer …
MC Díaz Flaqué, NM Galigniana, W Béguelin, R Vicario, CJ Proietti, ...
Breast Cancer Research 15, 1-24, 2013
452013
Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation
MA Rivas, M Tkach, W Beguelin, CJ Proietti, C Rosemblit, EH Charreau, ...
Breast cancer research and treatment 122 (1), 111-124, 2010
452010
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated …
R Schillaci, M Salatino, J Cassataro, CJ Proietti, GH Giambartolomei, ...
The Journal of Immunology 176 (6), 3426-3437, 2006
452006
Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer
CJ Proietti, W Béguelin, MCD Flaqué, F Cayrol, MA Rivas, M Tkach, ...
Steroids 76 (4), 381-392, 2011
312011
The system can't perform the operation now. Try again later.
Articles 1–20